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As fall begins, the Law & Health Care Program at Maryland Carey Law prepares for another academic year and a schedule of exciting 
programming that will include a roundtable to discuss the role of law in the 
opioid crisis, a panel presentation on the problem of drug pricing and the 
growing number of state laws attempting to address it, the annual Health 
Law Regulatory and Compliance Competition, and a planned Health Law 
Roundtable that will look at issues at the intersection of health law and 
bioethics. Most importantly, we welcome a new cohort of students including 
not only our JD candidates but also those admitted to the health law-focused 
LLM and Master of Science in Law programs. 
As the profiles below make clear, it has been a busy summer for the 
health law faculty, as they have developed and strengthened academic 
collaborations, both domestically and internationally, published important 
scholarly contributions, and continued to work at the forefront of health law 
scholarship and advocacy. 
Law & Health Care faculty members (from l to r) Leslie Meltzer Henry, Lauren Levy, Diane 
Hoffmann, Richard Boldt, Frank Pasquale, Karen Rothenberg, and Kathleen Hoke (not 
pictured: Sara Gold, Michael Greenberger, Amanda Pustilnik, and Deborah Weimer)
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Faculty Profiles
Richard Boldt 
Richard Boldt, the T. Carroll 
Brown Professor of Law, has been 
a member of the Maryland Carey 
Law faculty since 1989. In addition 
to constitutional law and criminal 
law courses, he teaches the mental 
disability law course in the health law 
program. He has written extensively 
on drug courts and other problem-
solving courts; his recent scholarship 
has focused on the legal system's role 
in mental health treatment. 
Professor Boldt has several articles 
in progress including an article to 
be published in an upcoming issue 
of the Drexel Law Review. In the 
article, entitled “Emergency Detention 
and Involuntary Hospitalization: 
Assessing the Front End of the Civil 
Commitment Process,” he discusses 
the dramatic shifts in the allocation 
of mental health treatment resources, 
notably the shift away from extended 
inpatient stays to a system that relies 
largely on outpatient care with brief 
inpatient stays during acute episodes. 
Several factors have contributed to 
this shift: the civil rights movement 
of the 1970s that ushered in an era 
of deinstitutionalization, advances in 
psychotropic medications facilitating 
faster stabilization of symptoms, and 
changes in health finance rules that 
saw states shifting the costs of care 
for those with severe mental illness 
to federal government insurance 
programs.
Although the care landscape has 
changed, the laws in many states that 
govern involuntary hospitalization 
have not been updated to reflect 
this current model of care. In these 
jurisdictions, an individual may be 
subject to involuntary commitment 
without timely judicial review. While 
the law may require judicial review 
within a set time period, the legal 
protections that such review is meant 
to provide are rendered moot if the 
statutory timeline exceeds the length 
of hospitalization. 
In Maryland, petitions for emergency 
commitment filed by a family member 
or friend must undergo judicial 
review. In contrast, mental health 
professionals and law enforcement 
may execute a petition without 
judicial review for up to 10 days 
with the possibility of extension for 
an additional seven days. This time 
period far exceeds the typical length of 
stay for most patients having an acute 
psychiatric episode.
While other states have updated 
their commitment laws to reflect the 
realities of current treatment and allow 
for judicial review at an earlier date, 
there still exist procedural hurdles 
such as the requirement that a patient 
request a hearing in order to trigger 
judicial review that may prove too 
burdensome for some individuals. 
Boldt argues that state laws regarding 
the involuntary commitment process 
should be updated to reflect current 
clinical realities and incorporate 
requirements for prompt mandatory 
judicial review. While acknowledging 
the key role that medical professionals 
play in that process, Boldt asserts 
that the legal system plays an equally 
important role in ensuring that 
constitutionally mandated protections 
of individual rights are observed.
Boldt's second article focuses on the 
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increasing use of non-professional 
peer support workers in mental 
health and substance abuse treatment 
settings. In the article, he explores the 
history of using community health 
workers (CHWs) to address health 
concerns such as HIV in developing 
countries. He then examines the 
barriers to implementing a similar 
model in the U.S. such as concerns 
related to reimbursement for such 
services, licensure issues as well as 
the interprofessional conflict that 
may result among professionals such 
as nurses and social workers who 
have traditionally provided case 
management services in health care 
settings. 
Boldt then reviews the implementation 
of this care model in several states via 
demonstration grants, highlighting 
those states that have overcome the 
obstacles by employing a team-based 
approach to care and reimbursement. 
He concludes that current evidence 
provides strong support for the 
community health worker model, 
particularly in low resource settings. 
CHWs, also called peer support 
specialists or navigators in the 
literature, play an important role in a 
more holistic, culturally competent 
model of care that achieves improved 
outcomes at the patient and population 
level. 
Leslie Meltzer Henry 
Professor Leslie Meltzer Henry has 
been a member of the faculty since 
2008. An attorney and bioethicist 
by training, her current research 
focuses on legal and ethical issues that 
arise in the context of research with 
pregnant women. With coauthors from 
across the country, Henry recently 
published an article in the Hastings 
Center Report, entitled “Research 
with Pregnant Women: New Insights 
on Legal Decision-Making,” that 
examines the role of lawyers in 
decision-making about the inclusion 
of pregnant women in research. The 
paper is based on work that Henry and 
several of her coauthors completed as 
part of their participation in the NIH-
funded PHASES Study (Pregnancy & 
HIV/AIDS: Seeking Equitable Study), 
which sought to address the systematic 
exclusion of pregnant women from 
HIV-related biomedical research. 
The authors draw attention to the 
exclusion of pregnant women from 
most clinical trials, the frequent 
decision by pharmaceutical companies 
not to seek FDA approval of drugs 
for use in pregnancy, and drug labels 
that acknowledge the lack of drug 
testing in pregnant women. The 
resulting dearth of evidence about how 
most drugs work in pregnant bodies 
not only leaves physicians treating 
pregnant women with insufficient 
data on which to base treatment 
decisions, it also means that most 
drugs taken during pregnancy are 
prescribed off-label, an outcome that 
the authors note shifts liability from 
the pharmaceutical company to health 
care providers.
Based on input from legal 
professionals engaged in the research 
process at different levels and contexts 
(e.g. general counsels representing 
academic institutions, attorneys 
for pharmaceutical companies, 
and former regulators), the authors 
discuss various factors that influence 
legal decision-making with regard 
to the inclusion of pregnant women 
in clinical research. They expand 
upon the frequently cited obstacles of 
liability and DHHS regulations about 
research with pregnant women, and 
they provide a more comprehensive 
analysis of the factors contributing to 
pregnant women's underrepresentation 
in research. The authors highlight that 
regardless of context (i.e. an academic 
institution or a pharmaceutical 
company), attorneys play an important 
role at each stage of the research 
process from conceptualization 
to FDA approval to post-approval 
marketing. 
Henry and her coauthors identify 
several factors that influence legal 
decision-making with regard to the 
inclusion of pregnant women in 
research, including financial factors, 
ambiguity and inconsistency in the 
regulatory language governing the 
inclusion of pregnant women in 
research, concerns regarding liability 
and risk management, and venue-
specific laws. In terms of financial 
factors, for example, the authors 
explain that pharmaceutical companies 
may have a financial disincentive to 
include pregnant women in research 
for drugs already approved for use in 
the general population because those 
drugs can be—and frequently are—
prescribed to pregnant women off-
label. Companies are able to avoid the 
potential delay in FDA approval and 
the additional cost that inclusion of 
pregnant women may entail. 
Despite obstacles, the authors 
conclude by emphasizing the critical 
need for guidance regarding the 
inclusion of pregnant women in 
clinical research, particularly in 
light of the recent outbreak of Zika 
virus and the continuing challenges 
presented by the HIV epidemic, and 
they recommend, as a starting point, 
careful review of legal decision-
making processes that have resulted 
in the inclusion of pregnant women in 
research. 
Diane Hoffmann
Diane Hoffmann, the Jacob A. France 
Professor of Health Care Law and 
Director of the Law & Health Care 
Program, recently returned from 
Aberdeen, Scotland, where she spent 
the month of July and early August 
teaching a course in Comparative 
Health Law, at the University of 
Aberdeen School of Law (see article 
about her experience on p. 13). In 
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about recent health law changes in 
Scotland and the U.K., Professor 
Hoffmann continued to work on 
her scholarly agenda. Hoffmann’s 
current scholarship focuses on the 
use and regulation of new health-
related technologies, products and 
procedures. She continues to work, 
for example, on examining the 
regulatory framework for microbiota 
transplantation, i.e., the transplantation 
of bacteria from a healthy individual 
to a patient recipient to cure or manage 
a health condition. In collaboration 
with co-investigators from the Schools 
of Law, Medicine and Pharmacy at 
the University of Maryland, she has 
been evaluating regulatory options for 
microbiota transplantation including 
fecal microbiota transplantation 
(FMT). With funding from the 
NIH, she has been able to convene 
a transdisciplinary working group 
of scientists, clinicians, bioethicists, 
government regulators, lawyers and 
representatives of the biotechnology 
and pharmaceutical industries 
to consider different regulatory 
approaches. 
Hoffmann and her co-investigators 
have held three working group 
meetings to date with an additional 
meeting planned for February 2018. 
As a result of her work in this area, 
she was invited by the editor of the 
journal Gut Microbes to submit an 
article for a symposium issue on gut 
microbiota transplants. The article, 
“A Proposed Definition of Microbiota 
Transplantation” written by Professor 
Hoffmann and several of her co-
investigators, was published earlier 
this year. 
Hoffmann and the study team recently 
completed a second article stemming 
from their work on the microbiome 
entitled “Regulation of Microbiota 
Transplantation: Balancing the Need 
for Information on Safety and Efficacy 
with Patient Access.” In the article, 
the authors take the position that the 
advent of microbiota transplants (e.g., 
fecal microbiota transplants to treat 
C. difficile) creates some challenges 
for regulators. There is no consensus 
on how these transplants should be 
regulated and the FDA has issued three 
draft industry guidance documents 
on the subject over the last four 
years, each one different than the one 
before. The challenge comes because 
the material that is transplanted – a 
community of living organisms – is 
unlike the small molecule chemical 
products that FDA typically 
regulates as drugs. Yet, the practice 
of microbiota transplantation is still 
relatively new and many argue we 
do not know all the potential adverse 
effects, especially long term, that the 
practice may have for patients. Others 
argue that there is enough evidence to 
show that the transplants, at least for 
C. diff., are both safe and effective and 
that they do not need to be regulated as 
drugs. The authors call for a regulatory 
framework for FMT that balances 
the need for additional research on 
safety and efficacy with appropriate 
patient access and recommends such 
a framework as a model for FMT 
as well as other types of microbiota 
transplants (e.g., vaginal, skin, nares 
and oral) that may be available in the 
future.
Professor Hoffmann gave a 
presentation on the topic of microbiota 
transplantation at the 4th ELSI (Ethical, 
Legal and Social Implications) World 
Congress. The meeting, held on the 
campus of UConn Health and the 
Jackson Laboratory for Genomic 
Medicine in Farmington, Connecticut 
in June 2017, was co-sponsored by the 
National Human Genome Research 
Institute, the Columbia University 
Medical Center, UConn Health, and 
the Jackson Laboratory. 
Hoffmann also continues to explore 
the changing legal and regulatory 
landscape for medical marijuana. In 
early June, she gave a presentation 
on the topic at the American Society 
of Law, Medicine and Ethics annual 
Health Law Professors conference 
at Georgia State University School 
of Law. She is currently preparing 
a manuscript analyzing the barriers 
to medical marijuana rescheduling 
at the federal level. In the article, 
she reviews recent decisions by the 
DEA and FDA declining to move 
cannabis from its current status as a 
Schedule I substance and examines 
the rationales presented in those 
decisions to assess the potential for 
rescheduling in the future. Hoffmann 
argues that the federal government’s 
current stance on rescheduling medical 
marijuana (i.e., requiring that cannabis 
go through the FDA drug approval 
process) is an insurmountable obstacle 
and thus it is raising false hopes 
for those requesting that the plant 
be rescheduled. She discusses the 
challenges posed by putting a plant 
through the drug approval process, in 
particular addressing consistency from 
batch to batch, safe administration and 
dosing.  Another challenge includes 
the willingness of a sponsor to take 
the financial risk of putting a plant 
through the process. Exclusivity would 
be a significant problem given the 
ability of patients to obtain medical 
marijuana for a number of conditions 
in over 28 states. 
Kathleen Hoke
Kathleen Hoke is Professor of Law 
and Director of the Network for 
Public Health Law, Eastern Region at 
Maryland Carey Law. Professor Hoke 
teaches a Public Health Law course 
at the school in addition to directing 
the Public Health Law Clinic. She 
also directs the law school's Legal 
Resource Center for Public Health 
Policy (LRC). The LRC provides 
legal guidance to state and local 
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governments, legislators and non-
governmental organizations on public 
health issues ranging from tobacco 
regulation to obesity prevention 
and assists with the development of 
policies that promote public health.
In her role as Director of the Network 
for Public Health Law, Eastern 
Region, she has been writing about 
scope of practice laws. Professor 
Hoke recently co-authored an article 
in the Journal of Law, Medicine & 
Ethics, entitled “Expanding Access to 
Care: Scope of Practice Laws.” Hoke 
and coauthor Sarah Hexem, Policy 
Director of the National Nurse-Led 
Care Consortium, examine the impact 
of scope of practice laws that govern 
allied healthcare professionals on 
health care provision and outcomes. 
Focusing on nurse practitioners and 
allied dental providers, they evaluate 
current scope of practice laws 
using the “Triple Aim” framework 
developed by the Institute for Health 
Improvement: better care, reduced 
healthcare costs and improved health. 
In the case of nurse practitioners, 
the authors argue that there is little 
evidence that legislative restrictions 
on their scope of practice (e.g. 
requiring physician collaboration) 
results in better care. In fact, there 
is no evidence of reduced quality of 
care in states that do not employ such 
restrictions. In terms of cost, studies 
have shown that nurse practitioners 
provide high quality care at costs 
equal to or lower than physician care. 
These studies, however, fail to account 
for the impact of restrictive scope of 
practice laws on cost.
In the case of allied dental providers 
(i.e. dental hygienists, therapists 
and assistants), the authors assert 
that expansion of scope of practice 
laws for these professionals may 
help to address persistent issues of 
access to proper dental care among 
historically underserved populations. 
Several promising approaches are 
currently being implemented in 
various states including the use of 
telemedicine to facilitate supervision 
by a dentist, removal of practice 
restrictions in specific designated 
settings, and expansion of dental 
provider categories to include dental 
therapists, i.e., mid-level professionals 
who can provide basic preventive 
and restorative oral healthcare. Each 
of these approaches may increase 
access to care, reduce health care 
costs, and result in improved health 
outcomes. The authors conclude by 
encouraging researchers to conduct 
formal evaluations of expanded scope 
of practice initiatives to assess their 
effectiveness and impact on population 
health.
Frank Pasquale 
Professor Frank Pasquale joined the 
faculty of the School of Law in 2013. 
His research focuses on various areas 
including health information law, 
health finance law and bioethics. 
Pasquale recently published, with 
coauthor Dr. Gordon Hull of the 
University of North Carolina 
Charlotte, an article in the peer-
reviewed journal Biosocieties entitled 
“Toward a critical theory of corporate 
wellness.” In the article, Pasquale 
and Hull examine the proliferation of 
corporate wellness programs under 
the rationale of improved employee 
health and decreased health care costs 
for employers. They argue that there 
is limited evidence to support that 
rationale. To date, the programs have 
not demonstrated their effectiveness in 
improving individual health outcomes 
and have not resulted in reduced health 
care expenditures for employers. In 
fact, the wellness programs themselves 
often cost more to implement than any 
savings enjoyed as a result of their 
implementation. 
Pasquale and Hull question the 
validity of corporate wellness 
programs on several grounds, apart 
from their failure to meet their 
stated goals. First, the programs are 
often premised on the notion that an 
individual’s health is almost entirely 
attributable to individual choices 
and behavior. Such a premise fails to 
account for important factors that are 
outside of individual control, namely 
genetic susceptibility, environmental 
exposure and disease etiology that 
may have little or nothing to do with 
individual health behaviors. 
Second, in contrast to early wellness 
programs implemented in the 1980s, 
participation in current programs 
is increasingly compulsory with 
associated incentives (e.g. discounted 
copays) and penalties (e.g. higher 
premiums, removal from coverage) 
to ensure employee participation 
and compliance. As the authors note, 
however, individuals confronting 
complex health conditions are often 
also those least able to meet the 
requirements of the programs and 
are therefore rendered even more 
vulnerable to poor health outcomes 
when program penalties are assessed. 
Programs that are structured in this 
manner effectively shift risk and cost 
on to the employee who is least able to 
absorb it. 
Third, the authors question the 
increasing use of surveillance 
and express concern about the 
encroachment of the workplace into 
employees’ personal lives through 
program reporting requirements 
and proliferation of wearable 
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technology that monitors health 
indicators and behaviors. Given the 
non-negligible expense of corporate 
wellness programs and the lack of 
evidence to support them in terms 
of improved health outcomes for 
employees or savings in healthcare 
costs to employers, the authors argue 
that investment in public health 
programs, which already undergo 
rigorous evaluation, typically employ 
evidence-based approaches and have 
demonstrated effectiveness, is a 
more promising approach to achieve 
wellness programs’ stated goals. To 
the extent that the wellness program 
model is employed, the authors 
advocate for changes to the federal 
regulatory framework to require 
employee input in wellness program 
development.
In addition to his research, Pasquale 
hosts the popular podcast “The 
Week in Health Law” with Indiana 
University law professor Nicolas 
Terry. Since 2015, Profs. Pasquale 
and Terry have been engaged in 
weekly conversations on the latest 
issues in the field. A recent broadcast, 
for example, looked at the issue of 
prescription drug pricing and featured 
Law & Health Care Program alumnus 
Ameet Sarpatwari, who currently 
serves as Assistant Director of the 
Program on Regulation, Therapeutics 
and Law at Harvard Medical School. 
For access to past podcasts, search 
for The Week in Health Law on your 
favorite podcast app. Show notes 
appear at http://twihl.com/.
Amanda Pustilnik
Amanda Pustilnik has been on the 
faculty at the Law School since 2010. 
In addition, she is a permanent faculty 
member at the Massachusetts General 
Hospital Center for Law, Brain & 
Behavior. Her research focuses on 
the intersection of neuroscience 
and the law, with a particular focus 
on the treatment and measurement of 
physical and emotional pain in legal 
contexts. 
Professor Pustilnik recently chaired 
the law and ethics section of a task 
force convened by the International 
Association for the Study of Pain 
(IASP) that issued the first guidance 
of any professional body on the uses 
of neuroimaging as legal evidence. 
This consensus statement, “Brain 
Imaging Tests for Chronic Pain: 
medical, legal and ethical issues and 
recommendations," appeared in Nature 
Reviews Neurology - https://www.
nature.com/nrneurol/journal/vaop/
ncurrent/pdf/nrneurol.2017.122.pdf. 
The consensus statement is broadly 
applicable to the neuroimaging 
of many subjective states, but 
focuses on chronic pain, a set of 
misunderstood conditions affecting 
up to 1/3 of people in their lifetime 
and costing legal and medical 
systems billions of dollars. The 
paper proposes criteria and standards 
for pain neuroimaging in clinical and 
legal settings, while emphasizing the 
need to protect parties and the legal 
system itself from unreliable data. 
The consensus statement is the 
result of work begun in 2014, when 
Professor Pustilnik and David 
Seminowicz, a professor in the 
Department of Neural and Pain 
Sciences at the University of Maryland 
School of Dentistry, convened a 
meeting of neuroimaging researchers, 
legal academics and judges to 
determine whether brain imaging 
techniques could be used in legal 
claims about pain. 
Professor Pustilnik also recently 
served as an advisor to the Aspen 
Institute's Health Strategy Group 
on the topic of the opiate epidemic. 
Co-chaired by Kathleen Sibelius 
and Tommy Thompson, the former 
secretaries of Health and Human 
Services under Presidents Barack 
Obama and George W. Bush, the 
group brought together expertise 
from government, private industry, 
and philanthropy, as well as scholars 
in law, economics, and addiction 
studies. The Health Strategy Group's 
recommendations will be published 
in late 2017, and will be focused on 
practical targets for reducing harm 
from the epidemic.
Karen Rothenberg 
Karen Rothenberg, Marjorie Cook 
Professor of Law and founding 
director of the Law & Health Care 
program, continues to pursue her work 
exploring the pedagogy of theater 
to engage audiences regarding the 
complex ethical issues associated with 
genome sequencing. 
She was recently invited to present 
a theatrical work as part of the 2017 
Annual Meeting of the AIDS Clinical 
Trial Group (ACTG) Network, 
held in Washington D.C. in June. 
Sponsored by NIH's National Institute 
of Allergy and Infectious Diseases, 
the ACTG is a network of domestic 
and international researchers, 
organizations, and advocates working 
to address HIV/AIDS and associated 
infectious diseases in low resource 
settings. 
The presentation, entitled “Bioethics 
in Play: The Drama of DNA,” 
examines the complexities that 
arise when incidental findings 
are discovered through genome 
sequencing. Rothenberg notes, “The 
Law & Health Care Program
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play challenges the audience to 
consider how to move forward with 
information discovered in the course 
of genome sequencing, recognizing 
resource limitations. The discussion 
also highlighted the complexity around 
informed consent and disclosure of 
incidental findings to family members 
who may have different values and 
approaches to the health concerns.”
Rothenberg and Dr. Lynn Wein 
Bush of Columbia University, her 
coauthor on the book The Drama of 
DNA, are also involved in a recently 
funded H3Africa ELSI study that 
will explore ethical issues in the 
disclosure of individual genetic 
research results. They will work 
with study investigators, as part of 
community engagement efforts, to 
adapt the narrative genomics approach 
for the participant community in South 
Africa.
This fall Professor Rothenberg and 
Dr. Bush will facilitate a discussion 
of Dr. Bush's new play premiering at 
the American Society of Bioethics and 
Humanities Annual Meeting in Kansas 
City, Missouri. The play focuses 
on genome sequencing in prenatal, 
neonatal, and pediatric settings, 
employing theatrical presentations to 
facilitate discussions of the challenges 
that healthcare providers face in 
working with families on the complex 
issues around decision-making, 
informed consent, and reporting of 
results.
In addition, Rothenberg continues 
to teach her externship workshop 
at NIH's National Human Genome 
Research Institute in Bethesda, 
Maryland. Students work in close 
collaboration with legal and policy 
experts as well as genetic scientists 
to examine the legal and ethical 
implications of emerging genetic 
technologies. In the spring semester, 
Rothenberg will again teach the survey 
course, Health Care Law & Policy, as 
part of the health law track of the new 
Master of Science in Law program.
Deborah Weimer, Professor of Law 
and Law & Health Care Program 
faculty member, established and 
directs the Health Care Delivery and 
HIV/AIDS clinic at the School of Law. 
The clinic, now co-directed by Visiting 
Assistant Professor Sara Gold, has 
been representing clients living with 
HIV since 1988. 
It was through her experience 
working in the clinic that Professor 
Weimer came to fully appreciate the 
critical role housing plays as a social 
determinant of health. The ability 
of individuals to engage in healthy 
behaviors and follow care regimens 
is largely predicated on access to safe 
and affordable housing.  Weimer and 
coauthors explored this issue in depth 
in the chapter “Patients and Families 
Living with HIV/AIDS” in Poverty, 
Health and Law: Readings and 
Cases for Medical-Legal Partnership 
(eds. E. Tobin Tyler, E. Lawton, et 
al.). In the chapter, they highlight 
the importance of stable housing to 
successful HIV/AIDS care and the 
increased vulnerability of individuals 
living with HIV/AIDS to “losing their 
housing due to rising medical and 
housing costs, reduced ability to work 
and discriminatory housing practices, 
among other factors.”
It was this need that led Weimer to 
develop a new clinical course at the 
law school, Landlord Tenant Clinic: 
Legal Theory and Practice, in 2013. 
Students represent tenants in housing 
court proceedings, individuals who are 
rarely able to secure legal counsel to 
represent them. Many of the clinic’s 
clients are referred from the law 
school's Health Care Delivery Clinic. 
A recent case involved exposure to 
lead paint; a family was referred by 
an HIV clinic after their fifteen-month 
old child, during routine blood work, 
was found to have elevated lead 
levels. The city health department 
got involved and the clinic filed a 
petition for breach of the warranty 
of habitability. As a result of the 
clinic’s representation, the landlord 
was ordered to complete lead paint 
remediation. Student attorneys also 
obtained rent abatement for the family 
during remediation. Weimer notes, 
“There is a regulatory system in place 
to deal with lead paint but enforcement 
remains an issue. In collaboration with 
community organization partners, we 
are advocating on behalf of our clients 
with the city council to expand rental 
licensing requirements to include 
single family homes. Licensing 
requires thorough home inspections 
including testing for lead paint prior 
to rental and will help to protect city 
residents from the negative health 
effects of substandard housing.” 
This summer, Professor Weimer 
published an article in the Hastings 
Race and Poverty Law Journal 
entitled “Deepening Lawyer Role 
Education to Serve Students and 
Society” where she advocates for 
wider recognition of access to justice 
issues in the law school curriculum. 
Weimer argues that failure to address 
the large numbers of individuals 
engaged in legal proceedings without 
(continued on page 18)
Housing as a Social Determinant of 
Health: Professor Deborah Weimer 
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The Law & Health Care Program conferred Health Law certificates 
on 35 graduating students at a 
breakfast reception on May 17, 2017. 
The reception marked the 20th year 
that certificates have been awarded to 
Maryland Carey Law students who 
have completed the rigorous academic 
and professional requirements that 
include health law coursework, 
practice-based learning, as well as a 
scholarly paper on a health law topic. 
Students in the health law program 
come from diverse backgrounds – 
some are seeking their legal education 
after significant experience in clinical 
settings as physicians, nurses and 
pharmacists. Others have engaged 
in advocacy and legislative work. 
They all share an interest in the 
legal and regulatory frameworks 
that support the health care system. 
In her remarks, Professor Diane 
Hoffmann, Director of the Law and 
Health Care Program, lauded the 
group for their active participation in 
the opportunities available to health 
law students, such as the Journal 
of Health Care Law & Policy, the 
Student Health Law Organization, 
and health law competitions such 
as the National Health Law Moot 
Court Competition. She noted the 
evolving health policy and legal 
climate and expressed her confidence 
in the graduates’ ability to tackle the 
challenges and opportunities that lie 
ahead. 
Below we highlight several of 
our 2017 graduates and their 
achievements:
Alexandra Jabs 
Alexandra was exceptionally 
productive and highly motivated as 
a law student, completing her MPH 
at the Johns Hopkins Bloomberg 
School of Public Health, serving on 
the Health Law Moot Court Team, 
as well as completing externship 
placements at the Johns Hopkins 
Health System and the U.S. Food 
and Drug Administration. She also 
served as a faculty research assistant 
to Professor Diane Hoffmann, 
conducting research on actions by 
the FDA and FTC against food and 
supplement manufacturers for false 
health claims. In addition, Jabs was 
a student in the Public Health Law 
Clinic. Clinic Director Kathi Hoke 
told the audience at the reception 
that Alexandra and her clinic 
partner Douglas Elliott “were like 
workhorses, completing a review 
of domestic violence legislation for 
all 50 states as well as the District 
of Columbia, developing individual 
fact sheets for each state and an 
issue brief that were subsequently 
published by the Network for Public 
Health Law.” Alexandra is now 
working in the Office of the General 
Counsel for the U.S. Food and Drug 
Administration.
Alison Best
Alison was a remarkably active 
student during her time at MD Carey 
Law serving as co-President of the 
35 Graduates Receive Health Law 
Certificate
2017 Health Law Certificate Graduates and L&HCP Faculty 
Law & Health Care Program
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Maryland Public Interest Law Project 
(MPILP), an officer of Maryland 
Carey Service Corps, and a member 
of the editorial board of the Maryland 
Law Review. In addition to these 
activities, Alison took full advantage 
of the many opportunities to engage 
in research and experiential learning, 
serving as a faculty research assistant 
and a law clerk with the Maryland 
Office of the Attorney General. 
She also performed admirably as a 
student attorney with the HIV/AIDS 
clinic at the law school. Clinic Co-
Director Sara Gold praised Alison’s 
many strengths and skills as a legal 
researcher, excellent writer and sharp 
thinker and commended her for her 
willingness to move beyond her 
comfort zone in working with clients 
and increasing access to justice for 
those in need. During her year in 
the clinic, Alison and fellow student 
Matthew Ulander worked diligently 
on a case that resulted in their client 
being awarded approximately $40,000 
in past disability benefits as well 
as monthly benefits going forward. 
Alison is currently serving as a judicial 
law clerk at the Maryland Court of 
Special Appeals.
Nadia Cheevers
Nadia Cheevers completed her law 
degree and health law certificate as 
an evening student while working 
full time and raising a family. Trained 
as a nurse, Nadia works as a Senior 
Risk Manager for the Maryland 
Medicine Comprehensive Insurance 
Program. In that position, she 
provides risk management support 
and education to the Departments of 
Surgery, Anesthesiology, Pathology 
and Ophthalmology at the University 
of Maryland Medical Center. In 
addition to this impressive list of 
responsibilities, Nadia also found time 
to work with Diane Hoffmann and 
Anita Tarzian, Program Coordinator 
for the Maryland Healthcare Ethics 
Committee Network, on a survey of 
health care facilities across the state 
to better understand how they are 
implementing the Medical Orders for 
Life Sustaining Treatment (MOLST) 
Law in the state. She was a major 
contributor to a manuscript about 
the survey that was accepted for 
publication in the Journal of Palliative 
Medicine. At the L&HCP certificate 
ceremony, Professor Hoffmann praised 
Nadia for her dedication and work 
ethic. Addressing her, Hoffmann said 
“I know it must have been difficult 
but you did it, you always had a smile 
on your face, and most importantly, 
you left a wonderful impression on 
everyone you interacted with.”
James Cook
As a student, James helped to launch 
one of the Drug Policy Clinic’s 
medical-legal partnerships at a local 
drug treatment program with the 
goal of ensuring that patients were 
enrolled in health insurance and could 
access drug treatment and other health 
services under Medicaid or private 
insurance. While James had planned 
to work on policy development 
when he entered the clinic, he agreed 
to work on this new initiative that 
provided invaluable legal assistance 
to many clients. Clinic Director and 
Professor Ellen Weber noted, “We 
watched James grow personally and 
professionally, as he gained confidence 
in his ability to help clients resolve 
their legal problems and work as part 
of a legal team. James demonstrated 
a level of empathy that we all strive 
for in our client representation and, 
as a result, he gained the trust of 
the program’s patients and became 
an indispensable resource to them.” 
Weber credits the medical-legal 
partnership’s success to James’ 
dedication and devotion to his clients. 
Marc Falvo 
Marc Falvo was an active member 
of the Law & Health Care Program, 
serving as Secretary of the Student 
Health Law Organization as well as 
student attorney with the law school's 
Health Care Delivery Clinic where 
he represented low-income clients 
living with HIV/AIDS. Falvo recently 
began his appointment as an Attorney 
Fellow with the Office of the General 
Counsel at the University of Maryland 
Medical System. Marc was selected 
for the fellowship opportunity from a 
competitive pool of applicants from 
Maryland Carey Law. 
Marc credited the coursework he 
completed as part of the Health Law 
Certificate Program, particularly 
the Business Aspects of Health Law 
course and Professor Pasquale’s 
Health Care Law & Policy course, 
in helping him to navigate this new 
role. “The Office of the General 
Counsel addresses legal issues for 12 
hospitals across the state. My health 
law coursework has helped to inform 
my work on assignments ranging from 
physician service agreements to Stark 
law to questions involving HIPAA, 
among others.” At the L&HCP 
certificate breakfast, Professor Frank 
Pasquale told the audience that “Marc 
Falvo has an outstanding career ahead 
of him.” 
2017 Health 
Law Graduate, 
Spencer Horseman 
(middle), with 
L&HCP Director 
Diane Hoffmann 
& Prof. Kathleen 
Hoke
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intersection of medicine and the law.
David Clark, an emergency 
department physician with the 
Maryland Emergency Medicine 
Network in 
Prince George’s 
County, 
followed a 
similar path to 
that of Cozanne 
Brent. After 
practicing 
medicine for 30 
years, Dr. Clark 
began to consider 
the next phase of his career and 
decided to explore graduate education. 
While researching programs in 
healthcare management, Dr. Clark 
learned about the health law MSL 
at the University of Maryland and 
decided to apply. He was motivated, 
he said, by the many changes that were 
happening in the field of medicine and 
the impact of laws like the Affordable 
Care Act on the practice of medicine. 
Dr. Clark said of his post-degree plans, 
“I am excited about the possibilities 
– to be able to shape policy and the 
future of medicine in a legal capacity.”
2017 Health Law Certificate Recipients 
Kehinde Ademulegun
Aoi Bae
Alison Best
Nadia Cheevers
Hillary Cleckler
Isabel Coello
James Cook
Ishan Dasgupta
Soutry De
Victoria Ekeanyanwu
Douglas Elliott
Marc Falvo
Spencer Horseman
Alexandra Jabs
Seungju Kang
Megan Kemp
Stella Kim
Michael LaBattaglia
Martha Marr
Martin McEnrue IV
Debra Mills
Holly Mirabella
Anaga Nmagu
Thomas Pacheco
Reena Palanivel
John Pardoe
Vincenzo Procopio
Drew Ricci 
Dena Robinson
Austin Roche
Hilary Roland
Emily Rosenberg
Cori Schreider
Danielle Smith
Matthew Ulander
Master of Science in Law Program 
Graduates its First Class 
This past May, the Master of Science 
in Law program at the 
University of Maryland 
Carey School of Law 
graduated its first class. 
The program offers 
several concentrations 
including health law. The 
health law concentration 
was developed in 
recognition of both 
the health law expertise at the law 
school, as well as the need for training 
among health care professionals in 
the increasingly complex legal and 
regulatory issues that drive the U.S. 
health care system. The program has 
been specifically designed to meet 
the needs of clinicians, health system 
administrators and federal regulators. 
Unique among MSL programs, 
each of the program’s courses has 
been specially designed for master’s 
students rather than JD students. In 
fact, the MSL courses are offered in 
College Park rather than in Baltimore.
The curriculum includes foundational 
courses in the U.S. legal system, legal 
research, ethics, the regulatory process 
and dispute resolution and negotiation. 
The health law courses in 
College Park include health 
care law and policy and three 
upper level courses: food and 
drug law, public health law, 
and health care reform.
Cozanne Brent, RN, BSN, 
is the prototypical MSL 
student in the health law 
concentration. A pediatric 
surgery nurse at the University 
of Maryland Medical Center, Ms. 
Brent was motivated to seek legal 
training after the passage of the 
Affordable Care Act. She observed 
the challenges patients faced in 
understanding their benefit changes 
as well as the difficulties the hospital 
faced in appropriately implementing 
policies to ensure compliance with 
the law. She recognized that she could 
serve as a better advocate and provide 
better care to her patients with an 
enhanced understanding of the legal 
and regulatory issues that impact 
their care. Having now completed the 
program, Cozanne is excited about the 
professional opportunities the program 
has made possible for her and she is 
looking forward to working at the 
2017 MSL Graduate, 
David Clark
2017 MSL Graduate, 
Cozanne Brent
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After ten years 
working with 
L&HCP Director 
Diane Hoffmann, 
Virginia Rowthorn 
is leaving the 
Program to become 
the Executive 
Director of 
the University 
of Maryland 
Baltimore’s 
Center for 
Global Education 
Initiatives. In her 
new role, she will lead the interprofessional global 
health activities for the campus-wide center with an 
emphasis on community-based research and service 
projects in international and domestic settings. She 
will also facilitate the Interprofessional Global Health 
Grant Program, an initiative that she conceived and 
implemented. Ms. Rowthorn has been serving as Co-
Director of the Center for the past three years. 
Ms. Rowthorn joined the School of Law in 2006 as 
the Coordinator of the Law & Health Care Program. 
In 2009, she was promoted to Managing Director, 
taking on additional responsibility for program 
administration. She has been actively involved 
in all aspects of the program including teaching 
the Health Law Practice Workshop, advising 
students in activities ranging from externships to 
regulatory competitions, as well as contributing to 
grant writing and administration of several federal 
grants and scholarship on telemedicine, microbiota 
transplantation and interprofessional global health 
education. 
Diane Hoffmann noted, “Rowthorn’s contributions 
to the Law & Health Care Program are innumerable. 
She has helped to shepherd this program to its current 
position as one of the leading health law programs 
in the country in addition to expanding opportunities 
for students, particularly in the area of global health. 
I know that she will enjoy great success in her new 
role.” 
Virginia Rowthorn 
to Lead Global Health 
Education Initiative
The Law & Health Care Program is pleased to 
announce the appointment of Lauren Levy as its new 
Managing Director. Ms. Levy is a 2011 graduate 
of the School of Law and the health law certificate 
program. She comes to the law school from the 
University of Maryland School of Medicine where 
she served as a faculty Research Associate in the 
Department of Epidemiology & Public Health and 
Assistant Director of Research for the Maryland 
Center of Excellence on Problem Gambling. Ms. 
Levy has worked in the field of public health for 
more than 20 years in domestic and international 
settings including the development of reproductive 
health programs in Latin America and the Caribbean, 
evaluation of maternal and child health interventions 
in West Baltimore and management of an NIH-funded 
career development program in women’s health, 
among other roles.
Her health law experience includes positions 
in the Medicaid Division of the then-Maryland 
Department of Health and Mental Hygiene (now 
the Maryland Department of Health) office of the 
Maryland Office of the Attorney General, where she 
drafted appellate briefs for cases involving Medicaid 
eligibility determinations; a private employee benefits 
consulting practice, working with clients to interpret 
various provisions of the Affordable Care Act; and an 
elder law firm.
In addition to her 
JD, Ms. Levy 
holds a Master 
of Public Health 
degree from 
the Columbia 
University 
Mailman School 
of Public Health. 
Law & Health Care 
Program Welcomes 
New Managing 
Director Lauren levy
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Frank Pasquale, Professor of Law at Maryland Carey Law, was recognized 
as one of the top ten most cited authors in health law scholarship, 
according to an analysis conducted by two prominent health law experts. 
Professors Mark Hall of Wake Forest University School of Law and I. Glenn 
Cohen of Harvard Law School presented the results of their analysis in 
a post published on Harvard’s Petrie-Flom Center for Health Law Policy, 
Biotechnology and Bioethics blog. The authors found that Professor 
Pasquale's work was cited approximately 300 times between 2010 and 
2014. 
Pasquale has written across several subfields in health law, including health care finance and regulation, 
bioethics, and data protection. 
For example, he has researched health data policy in work that recognizes both the rapidity of technological 
advances and the unintended consequences of the interaction of legal rules (such as privacy, intellectual 
property, and antitrust laws).  In the co-authored piece, “Protecting Health Privacy in an Era of Big 
Data Processing and Cloud Computing,” Pasquale and Tara Ragone combined careful analysis of the 
implications of the HIPAA Omnibus Rule with interviews with leading attorneys about optimal methods of 
implementing security and other safeguards. Pasquale’s work is among the leading U.S. legal research 
cited relating to regulation of algorithmic ranking, scoring, and sorting systems
In health care finance, Pasquale has completed a trilogy of articles explaining the law and policy of tiering 
in national and international health systems, and proposing reforms. These articles covered the complex 
legal regulation of concierge medicine, single-specialty hospitals, and access to patented drugs. Each 
article unraveled the complex interactions among providers, insurers, and regulators, to expose the ways in 
which seemingly neutral regulatory decisions could either exacerbate or alleviate health disparities.
In bioethics, Pasquale’s early work explored the ethics of human enhancement from the perspective of 
political economy (including analyses of genetic engineering and cognition-enhancing drugs). He has 
recently critiqued the rise of corporate wellness programs in an article in Biosocieties (discussed on page 
5 of this newsletter). Pasquale’s approach attempts to set the study of corporate wellness on a new path, 
away from technocratic experimentalism, and toward more democratic participation in the definition and 
pursuit of “wellness.”
At present, Pasquale is working on several health law-focused research projects, including an article on 
reimbursement for medical robotics, an analysis of the interaction of privacy and human subject research 
regulations, and a study of health care expenditures based on the emerging methodology of law and 
macroeconomics.  
The full ranking can be found here: http://blogs.harvard.edu/billofhealth/2017/04/18/most-cited-health-
law-scholars/
Professor Frank Pasquale Recognized as 
Leading Health Law Scholar
Law & Health Care Program
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It has been more than thirty years since a nursing colleague 
encouraged Randi Kopf to 
pursue her legal education. At 
the time, Ms. Kopf was teaching 
in the graduate program of the 
University of Maryland School 
of Nursing as well as working 
as a family oncology nurse 
practitioner. She would often 
delve into the ethical and legal 
issues that arise in the healthcare 
setting with her students and 
she thought that training in the 
law would help to inform her 
teaching. 
Given her connection to the 
University of Maryland, the 
School of Law seemed like 
a natural fit. She entered the 
law school just as the Law 
& Health Care Program was 
being developed by Professors 
Karen Rothenberg and Diane 
Hoffmann. She notes, “In 
addition to a number of nurses, 
there were many other clinicians 
attending – physicians, dentists. 
It was a very exciting time to be a 
part of the program.”
As an oncology nurse practitioner, 
Kopf was no stranger to the role of law 
in health care matters. She frequently 
found herself involved in legal issues 
with patients such as wills, patient 
rights, visitation, etc. “Now cancer 
can be considered a chronic illness. 
Back then, cancer patients had a much 
shorter life expectancy. There was an 
urgency to the issues that came up, 
these end-of-life legal issues required 
timely action.” 
Kopf recalls of her days at the law 
school, “I took every health law course 
that I could. These courses as well as 
contracts, torts and administrative law 
inform my legal practice to this day.” 
Kopf was also fortunate to complete 
an internship at the National Institutes 
of Health Office of the General 
Counsel. “The general counsel at NIH 
is truly working at the nexus of law 
and medicine. That experience really 
solidified it for me. I knew that I was 
going in the right direction,” Kopf 
says of her internship experience. 
After graduation, Kopf jumped into 
the field with both feet. She accepted 
a position in the Health Law practice 
group of Nixon, Hargrave, Devans & 
Doyle (now Nixon Peabody) and she 
was invited to serve on the Maryland 
legislative committee that was 
responsible for writing the first Health 
Care Decisions Act for the state. That 
was the first of many invitations 
Kopf has received over the 
years to contribute her unique 
expertise as a nurse attorney. 
After several years at the law 
firm, Kopf decided to establish 
a solo practice, Kopf Health 
Law, LLC. In her practice, Kopf 
works with physicians and other 
health care providers on issues 
ranging from medical practice 
establishment and acquisition, 
employment agreements, 
contract negotiation, 
administrative regulatory 
issues and health information 
technology matters.  
Apart from her dedication to 
clients, Kopf is also deeply 
committed to service, in the 
profession and beyond. She 
has been active in professional 
organizations serving as Chair 
of the Health Law Section of 
the Montgomery County Bar 
Association and as a member 
of the health law section of the 
Maryland State Bar Association. She 
supports her fellow nurse attorneys 
through, among other activities, 
leadership roles with The American 
Association of Nurse Attorneys 
(TAANA) and Chesapeake Nurse 
Attorneys, Inc. 
She has been called upon by 
Congressional Committees, patients’ 
rights groups and others to educate 
and advocate. She recalled a recent 
example where the National Labor 
Relations Board released guidelines 
regarding the use of social media for 
employers that directly conflicted with 
HIPAA regulations. Kopf was able to 
Law & Health Care Program 
Alumni Spotlight: Randi Kopf ’89
MD Carey Law alum, Randi Kopf, with Anita Hill, Professor 
Brandeis University Heller School for Social Policy 
and Management
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advocate for her clients and the board 
then issued exceptions and additional 
guidance for health care employers. 
That recent case drew on Kopf’s 
significant expertise at the intersection 
of healthcare and technology. She 
lectures and writes frequently for 
both lawyers, clinicians, and patients, 
helping each group to successfully 
navigate the electronic age in 
healthcare. She has recently given 
talks, for example, regarding the use 
of social media in health care settings 
as well as legal practices. 
A recent career highlight for Kopf 
was the opportunity to present Anita 
Hill, Professor at Brandeis University 
Heller School for Social Policy 
and Management, with the Mary 
Eleanor McGarvah Award at TAANA 
Foundation’s 35th Annual Meeting and 
Educational Conference in Boston, 
MA. Professor Hill was recognized 
for her contributions to equal justice, 
social justice and support of women’s 
rights.
Kopf says, “People sometimes ask 
me why I became an attorney if I 
loved being a nurse practitioner. The 
way I see it, each of my degrees and 
professional experiences have built 
on each other. It has been a natural 
progression from providing care 
to patients as a nurse, beginning to 
address end-of-life legal issues as an 
oncology nurse practitioner, to serving 
as an attorney-advocate for health 
care professionals and patients. It has 
been a continuum. I love being a nurse 
attorney and the health law program at 
the University of Maryland prepared 
me well.”
L&HCP Professor Kathi Hoke was awarded the 
Jennifer Robbins Award for the Practice of Public 
Health Law by the Law Section of the American 
Public Health Association at the organization’s 2016 
Annual Conference. The award is given to mid-career 
professionals in recognition of “outstanding dedication 
and leadership in the field of public health law” and is 
named in honor of Jennifer Robbins, a public health 
lawyer who practiced in the Office for Civil Rights at 
the U.S. Department of Health, Education and Welfare. 
She subsequently served as an Assistant Attorney 
General in Maryland and principal counsel for the 
state’s Department of Health and Mental Hygiene. 
Like Robbins, Professor Hoke spent a number of years 
working as an Assistant Attorney General in Maryland 
and has devoted her career to the integration of law into 
public health. Professor Hoke remarked, “It is an honor 
to be recognized by my peers in the APHA Law Section 
and I am particularly honored to receive this award in 
memory of Jennifer Robbins.”
L&HCP Professor Kathleen Hoke Receives 
National Award for Contributions to  
Public Health Law
Law & Health Care Program
Spring Newsletter 2017 Pg 15 
In July, a Maryland Carey Law team 
spent two weeks in 
Malawi alongside 
Chancellor College 
of Law faculty and 
students to study 
how law school 
clinics can be used to 
address environmental 
and public health 
injustices. The project 
was sponsored by the 
Law & Health Care 
Program (L&HCP) 
and the Environmental 
Law Program at the School of 
Law, the University of Maryland 
Baltimore Center for Global Education 
Initiatives (CGEI) and the University 
of Malawi Chancellor College Faculty 
of Law (Chanco). The Maryland Carey 
Law team was comprised of Professor 
Bob Percival, Robert F. Stanton 
Professor of Law and Director, 
Environmental Law Program; Virginia 
Rowthorn, (then Managing Director 
of the L&HCP and now Director 
of CGEI), health law student Julia 
Kenny (2L), environmental law 
student Taylor Lilley (3L), and Atiji 
Pheri (LLM, Environmental Law ’17) 
who is from Malawi. On the Malawi 
side, Professor Chikosa Banda, Dean 
Garton Kamchedzera, and Patrick 
Chinguwo, the Director of the Clinical 
Program led the project.
This year’s project was the latest 
in a long collaboration between the 
University of Maryland Baltimore 
(UMB), Maryland Carey Law and 
Chanco. It began in 2010 when CGEI 
sent an interprofessional team of 
faculty and students to Malawi to 
study the health and legal needs of 
orphans and vulnerable children. The 
project was designed to teach students 
the value of an interprofessional 
approach to global health. The project 
was sited in Malawi because UMB, 
through School of Medicine faculty 
member Miriam Laufer, had an 
ongoing NIAID grant in Blantyre, 
Malawi. That study provided 
an infrastructure to support the 
interprofessional project and a vehicle 
to engage with community members, 
health professionals, and health and 
human rights lawyers.  
In the summer of 2013, L&HCP 
Director Diane Hoffmann and 
Maryland Carey Law Professor 
Peter Danchin traveled to Malawi 
and worked with Professor Chikosa 
Banda to organize a workshop for 
students and faculty from both 
universities on the subject of HIV/
AIDS. In subsequent years, Professor 
Banda and others from Chanco have 
visited Maryland Carey Law for 
joint meetings and conferences. A 
specific focus of one of these meetings 
was clinical legal education and the 
University of Malawi’s progress in 
this area. In the last 
eight years, Chanco has 
developed a number 
of legal clinics on 
various topical areas 
including disability 
and HIV issues. In 
2016, Professor Banda 
proposed a visit by 
Professor Percival to 
Malawi to support 
Chancellor College’s 
fledgling Environmental 
Justice and Sustainability 
Clinic. Percival created 
the law school’s 
Environmental Law Clinic.
Clinical legal education is a relatively 
recent development in Malawi but is 
developing at a rapid pace. To date, 
Chanco’s clinics have been initiated 
based on student interest in a particular 
topic. Participation in the clinics is 
voluntary and not credit bearing. 
Recently, however, Malawi’s Council 
on Legal Education approved a 
revised curriculum that requires more 
opportunities for students to engage in 
practice-based education during their 
four years of law school.  
Chanco’s Environmental Law and 
Sustainability Clinic was started in 
2014 and was designed to support 
advocacy and litigation around 
environmental and public health 
issues. The group has engaged in 
community outreach activities, 
including clean-ups in the Chanco 
and Zomba area, tree planting, and 
street law activities targeting primary 
schools and community members 
(mainly communicating environmental 
messages).
The project commenced with a day of 
presentations and discussion on the 
Public Health and Environmental 
Law Project in Malawi Brings Law 
School Team Close to Nature
Maryland Carey Law team with Chancellor College 
Faculty of Law faculty and students
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topic of environmental justice, public 
health, and the role of clinical legal 
education in promoting both. The 
workshop took place at a time when 
these themes are in a transformative 
moment in Malawi. The Malawian 
Parliament recently approved a new 
Malawi Environment Management 
Act (EMA) that created a new 
Environmental Protection Authority. 
The agency will have greater 
enforcement authority than did the 
Environmental Affairs Department 
of the Ministry of Natural Resources 
which depended on the Department 
of Justice to perform enforcement.  
Environmental law is an area with 
robust opportunities for a legal 
clinic to provide technical assistance 
to the government and NGOs and 
to represent communities in legal 
challenges.  
The workshop was a fruitful source 
of discussion focused on approaches 
to clinical legal education in various 
jurisdictions and the pros and cons 
of emulating such approaches in the 
Chanco curriculum.  When some 
Chanco students noted that not all 
Malawian law students want to 
litigate and, further, may be hesitant 
or unenthused about taking on 
politically-charged legal issues, 
Professor Percival described 
how the the Maryland Carey 
Clinical Law Program takes 
an expansive view of the law’s 
role in environmental justice 
and public health by engaging 
students in negotiation, 
advocacy, advising clients, 
as well as litigation. These 
classroom discussions were 
followed by several site 
visits across Malawi. The 
faculty and students from 
both schools traveled in 
convoy which proved to 
be a rich and fun source of 
bidirectional learning. The 
trip included an encounter 
with a group of 20 
elephants that (peacefully) 
surrounded their car on a quiet road 
in a game reserve. The site visits 
included the office of the Leadership 
for Environment and Development 
(LEAD) Initiative, a group that 
undertakes capacity building and 
action projects that support climate 
change adaptation, public health and 
environmental development. It helps 
other local institutions by providing 
objective information and practical 
policy and program proposals that 
foster environmentally sound and 
socially equitable development. 
LEAD values an interprofessional 
approach to public health and 
environmental justice as evidenced 
by its intensive program for law 
students. One issue that requires an 
interdisciplinary approach is the use 
of treated mosquito nets for fishing, 
a common practice. Addressing 
this practice requires public health, 
environmental, and social work 
professionals.
In addition, the group visited 
attorneys working for the Malawian 
Environmental Affairs Department; 
a fishing site and cholera hotspot in 
Lake Chilwa; the Mulanje Mountain 
Conservation Trust; the Centre for 
Environmental Policy and Advocacy 
(CEPA); and the Mudi River 
which runs through Blantyre City. 
The Mudi river is heavily polluted 
by industrial waste and sewage. 
CEPA is making efforts to have 
the sewer pipes rehabilitated 
and also lobbying to have 
the government release funds 
allocated for the rehabilitation of 
the city’s entire sewage system.
To close out the project, the 
Maryland and Chanco teams 
met to discuss extending 
this valuable teaching and 
learning collaboration 
through joint scholarship, 
teaching, and experiential 
learning opportunities on 
both sides. The July trip was 
generously supported by the 
David and Leslie Glickman 
Interprofessional Health Law 
Fund.
Joint symposium on Environmental Law 
and Public Health
University of Malawi Chancellor College Faculty of Law
Maryland Carey Law and Chancellor College 
Symposium Presenters
Professor Chikosa Banda (left) introducing 
Maryland Professor Bob Percival
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I had the good fortune to spend most of the 
month of July and the 
first week of August 
teaching at the summer 
program in comparative 
law at the University of 
Aberdeen – a collaboration 
between the University of 
Baltimore and University 
of Maryland Schools of 
Law, in Baltimore, MD and 
the University of Aberdeen 
School of Law in Aberdeen, 
Scotland. 
This trip was the realization of a 
long held aspiration for me. During 
my dozen years as Associate Dean 
at Maryland, it was often my job 
to select the faculty member who 
would have the opportunity to 
teach and live in Aberdeen for 
the summer program. Sadly, I 
was unable to choose myself so 
had to wait until I stepped out of 
the Dean’s office and back to the 
faculty before I was able to put my 
hat into the ring of potential faculty 
members who might be selected 
for this unique opportunity. I was 
especially excited to be chosen this 
past year as Maryland faculty who 
have been to Aberdeen and taught 
in the program have had wonderful 
things to say about it.  
I was also excited by the prospect 
of teaching a comparative health 
law course. At Maryland, I have 
taught numerous health law courses 
ranging from our survey course, 
Health Care Law & Policy, to 
specialized courses on End of 
Life Care and Health Care for the 
Poor, among others. Although I 
had taught a Comparative Health 
Law course several years ago, I had 
not had the opportunity to focus on 
one other country and to have experts 
from that country come and lecture in 
the course. That was a big attraction 
of the Aberdeen course for me. Prior 
to the summer, I worked with then 
head of school Anne-Michele Slater 
and Professor Greg Gordon (the 
current head of school) to prepare for 
the course. I shared my vision for the 
course with them and Anne-Michele 
and Greg identified a stellar group of 
guest speakers.  
The course focused on a comparison 
of four areas of health law and 
policy between the U.S. and the 
United Kingdom/Scotland: health 
care systems, medical malpractice 
systems, allocation of scarce health 
care resources, and regulation of the 
beginning and end of life. Our guest 
speakers were able to speak to each 
of these areas of law. They included 
Peter Feldschreiber, a dually qualified 
physician and barrister from London 
who specializes in the regulation 
of pharmaceuticals and medical 
devices and who advises both E.U. 
and U.S. health product companies 
on all aspects of European 
regulatory law; Neil MacLeod, a 
solicitor with the NHS litigation 
department in Scotland; Annie 
Sorbie and Edward Dove, both 
of whom specialize in health and 
medical law and have recently 
received faculty appointments 
at the University of Edinburgh; 
and Prof. Scott Styles, a member 
of the faculty at University of 
Aberdeen, who, among other things, is 
an expert in medical ethics. 
Each of these guest speakers added 
a great deal of excitement to our 
class discussions as they helped us 
to compare the “system” in the U.S. 
with that of the U.K./Scotland. Several 
current events also made the course 
come alive for me and the students. 
The first was the advent of Brexit 
which is provoking much uncertainty 
in the medical profession regarding 
movement among the E.U. countries. 
One article in the news indicated that 
over half of E.U. health professional 
workers in the U.K. would leave. 
Brexit has also raised anxiety in the 
pharmaceutical and medical device 
industries about what will be required 
in the U.K. in terms of new product 
approval and marketing authorizations 
and whether the U.K. will remain 
a part of the European Medicines 
Agency (EMA). 
A second relevant event for the 
course was the case of Charlie 
Gard, the infant in the U.K. who 
had a rare terminal genetic disorder 
(mitochonadrial DNA depletion 
syndrome) that left him blind, deaf 
L&HCP Director Diane Hoffmann Reflects on  
Teaching in Aberdeen
Photo credit: Richard Frew Photography
Prof. Diane Hoffmann (center) at Kings College, Aberdeen, with 
Prof. John Bessler, University of Baltimore School of Law and 
Prof. Anne-Michele Slater, University of Aberdeen School of Law
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and unable to breathe on his own. 
His doctors and the hospital where 
he was receiving care felt that his 
case was hopeless and they should 
not be required to continue to treat 
him. His parents, however, took the 
case to court, fighting for the hospital 
to be required to keep Charlie on 
life support so that he could receive 
experimental treatment. Each day 
there were new developments in the 
case including the Pope and President 
Trump offering to do whatever they 
could to help the parents in their 
quest to keep the child alive. The case 
offered the class a chance to consider: 
What constitutes “futile” medical 
treatment? Who should make the 
decision to withdraw life sustaining 
treatment for a child in this condition- 
the parents, the doctors, or the courts? 
And what is in the child's best interest?
The students enthusiastically met the 
challenge of debating the different 
aspects of health law and how they 
played out in the two different 
jurisdictions. Their keen interest in the 
issues under discussion made the class 
sessions lively and fun for me. The 
model of co-teaching a comparative 
health law class with experts from 
the jurisdictions being compared is a 
wonderful format for the faculty and 
the students.
Housing as a Social Determinant of Health: 
Professor Deborah Weimer... continued from pg 7
the ability to afford legal counsel 
comes at a significant cost, both 
economic and otherwise, to the 
individual and society. It also calls 
into question the court system’s ability 
to meet its constitutionally mandated 
commitment to due process.
Although she advocates for the 
inclusion of more in-depth discussion 
of access to justice concerns as part 
of civil procedure coursework, she 
argues that clinical legal education can 
be especially instructive is this regard. 
She writes: “…the most powerful way 
to engage students in understanding 
the failure of our current system is to 
involve them in representing clients 
whose rights would go unprotected but 
for their assistance.” It is this firsthand 
exposure, she posits, that provides the 
most vivid illustration of the problem 
of lack of access to counsel. 
She concludes by advocating for 
additional instruction to law students 
regarding their responsibility, both 
professional and moral, in cases where 
the opposing party is unrepresented, 
questioning the appropriateness of 
zealous advocacy in such contexts and 
warning against actions that exploit 
the power imbalance in such cases. 
Weimer touts innovative legal service 
provision models, such as medical-
legal partnerships, encouraging 
interdisciplinary efforts to evaluate 
such models as potential remedies to 
the access to justice crisis facing the 
legal system.
Kings College University of Aberdeen, Scotland
Traditional scottish bagpiper at Dunnottar Castle, Aberdeen, Scotland
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Long-time Law & Health Care Program faculty member Ellen 
Weber has been appointed Vice 
President for Health Initiatives at 
the Legal Action Center, a non-
profit law and policy organization 
in Washington, D.C., dedicated to 
advocacy on behalf of individuals 
with HIV/AIDS, criminal records and 
histories of addiction. Her new role 
at the LAC is a homecoming of sorts 
as Professor Weber worked for the 
organization from 1985 to 2002. 
In 2002, Professor Weber joined the 
faculty at Maryland Carey Law. She 
established and directed the Drug 
Policy and Public Health Strategies 
Clinic, where she and clinic students 
Ellen Weber named Vice President 
for Health Initiatives of the Legal 
Action Center
focused on policy development 
to expand access to substance use 
treatment services. In recent years, 
Professor Weber and her students had 
focused on the implementation of the 
Affordable Care Act and the Mental 
Health Parity and Addiction Equity 
Act, supported by grant funding form 
the Open Society Foundation. 
The Parity Act is a federal law 
that requires insurers to provide 
coverage to those with mental health 
or substance use problems that is 
comparable to the coverage provided 
to those with other medical problems.  
“At the clinic, we have used the 
Parity Act to try to get the most 
expansive, nondiscriminatory health 
benefit for patients with mental health 
and substance use disorders,” Weber 
said. “We feel we’ve accomplished 
a lot by advocating for strict 
enforcement of that law in our state.”
Her new role at the Legal Action 
Center will also examine “how the 
parity law is being implemented both 
on the national level and in states,” 
Weber added. “We also will be 
developing litigation to enforce the 
parity act where we think litigation 
is necessary. I’ll be working to adapt 
and transfer to other states some of 
the enforcement strategies we’ve used 
through our work in Maryland.”
Weber’s new role is the next phase 
in her always diverse approach to 
this dynamic issue. “We’ve used 
the Parity Act and other Affordable 
Care Act protections in every 
way that we can to try to identify 
insurance coverage problems and 
fix those problems, from legislative 
activities to regulation development 
with agencies to individual client 
representation,” Weber said. “We use 
a variety of different strategies to take 
on these barriers that limit access to 
health care.”
L&HCP Director Diane Hoffmann 
said of Professor Weber’s departure, 
“Ellen’s contributions to the laws 
and policies regarding substance 
use disorder at the state and federal 
level are countless. We know that she 
will continue to serve as a staunch 
advocate for those struggling with 
addiction as well as those in recovery. 
We look forward to Ellen’s continued 
collaboration with the Law & Health 
Care Program as she moves into 
her new role. We are fortunate that 
our students will continue to have 
the opportunity to work with Ellen 
on these important legal and policy 
issues as externs with the Legal 
Action Center.” 
Tune in to The Week in Health Law, a weekly podcast 
hosted by our own Professor Frank Pasquale and 
Professor Nicolas Terry, Executive Director of the 
Hall Center for Law and Health at Indiana University 
McKinney School of Law, that engages various guests 
in conversations about a wide range of issues in 
health law and policy.
To access this podcast, search for The Week in Health 
Law on your favorite podcast app. Show notes appear 
at http://twihl.com/.
500 West Baltimore Street
Baltimore, MD 21201
www.law.umaryland.edu/healthlaw
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The Week in Health Law podcast
